KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Royalty Pharma (RPRX) Return on Assets (2020 - 2025)

Historic Return on Assets for Royalty Pharma (RPRX) over the last 6 years, with Q4 2025 value amounting to 0.07%.

  • Royalty Pharma's Return on Assets fell 100.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.07%, marking a year-over-year decrease of 100.0%. This contributed to the annual value of 0.07% for FY2025, which is 100.0% down from last year.
  • Royalty Pharma's Return on Assets amounted to 0.07% in Q4 2025, which was down 100.0% from 0.07% recorded in Q3 2025.
  • In the past 5 years, Royalty Pharma's Return on Assets registered a high of 0.12% during Q2 2021, and its lowest value of 0.01% during Q4 2022.
  • Moreover, its 5-year median value for Return on Assets was 0.07% (2022), whereas its average is 0.07%.
  • As far as peak fluctuations go, Royalty Pharma's Return on Assets tumbled by -800bps in 2021, and later skyrocketed by 900bps in 2023.
  • Over the past 5 years, Royalty Pharma's Return on Assets (Quarter) stood at 0.07% in 2021, then plummeted by -81bps to 0.01% in 2022, then soared by 691bps to 0.11% in 2023, then crashed by -30bps to 0.07% in 2024, then decreased by -7bps to 0.07% in 2025.
  • Its last three reported values are 0.07% in Q4 2025, 0.07% for Q3 2025, and 0.09% during Q2 2025.